| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 200.592.879 $ | -125.835.397 $ | -38,5 % | 1 | 326.428.276 $ | -220.095.197 $ | -40,3 % | 1 | 546.523.473 $ | +546.523.473 $ | 1 | |||||
| Caris Life Sciences, Inc. | CAI | → 0 | Schwach | 200.592.879 $ | -125.835.397 $ | -38,5 % | 1 | 326.428.276 $ | -220.095.197 $ | -40,3 % | 1 | 546.523.473 $ | +546.523.473 $ | 1 | |
| 200.592.879 $ | -125.835.397 $ | -38,5 % | 1 | 326.428.276 $ | -220.095.197 $ | -40,3 % | 1 | 546.523.473 $ | +546.523.473 $ | 1 | |||||